Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis

Annals of Neurology

Volumn 55, Issue 6, 2004, Pages 793-800

  Barcellos, Lisa F ^a,b   Begovich, Ann B ^c,f   Reynolds, Rebecca L ^c   Caillier, Stacy J ^a   Brassat, David ^a   Schmidt, Silke ^d   Grams, Sarah E ^c   Walker, Karen ^c   Steiner, Lori L ^c   Cree, Bruce A C ^a   Stillman, Althea ^a   Lincoln, Robin R ^a   Pericak Vance, Margaret A ^d   Haines, Jonathan L ^e   Erlich, Henry A ^c   Hauser, Stephen L ^a   Oksenberg, Jorge R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CELERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 17Q; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NOS2A GENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN AMERICANS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 17; EXONS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR2 ANTIGEN; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MULTIPLE SCLEROSIS; NITRIC OXIDE SYNTHASE; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

EID: 2542630553     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20092     Document Type: Article

References (49)

1. Hauser SL, Goodkin DE. Multiple sclerosis and other demyelinating diseases. In: Braunwald E, Fauci AD, Kasper, DL, Hauser, SL, Longo, DL, Jameson, JL, Eds. Harrison's principle of internal medicine. 15th ed. New York: McGraw Hill, 2001.
2. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet 1996;13:472-476.
3. Haines JL, Ter-Minassian M, Bazyk A, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996;13:469-471.
4. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-468.
5. Kuokkanen S, Gschwend M, Rioux JD, et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997;61:1379-1387.
6. Chataway J, Feakes R, Coraddu F, et al. The genetics of multiple sclerosis: principles, background and update results of the UK systematic genome screen. Brain 1998;121:1869-1887.
7. Haines J, Terwedow H, Burgess K, et al. Linkage of multiple sclerosis to the MHC is explained by association to HLA-DR2. Hum Mol Genet 1998;7:1229-1234.
8. Broadley S, Sawcer S, D'Alfonso S, et al. A genome screen for multiple sclerosis in Italian families. Genes Immunol 2001;2:205-210.
9. Dyment DA, Willer CJ, Scott B, et al. Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics 2001;3:145-151.
10. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-1517.
11. Risch N. Searching for genetic determinants in the new millennium. Nature 2000;405:847-856.
12. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33(suppl):228-237.
13. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-933.
14. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
15. Wall JD, Pritchard JK. Assessing the performance of the haplotype block model of linkage disequilibrium. Am J Hum Genet 2003;73:502-515.
16. Tabor HK, Risch NJ, Myers RM. Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:391-397.
17. Barcellos LF, Oksenberg JR, Green AJ, et al. Genetic basis for clinical expression in multiple sclerosis. Brain 2002;125:150-158.
18. Barcellos LF, Oksenberg JR, Begovich AB, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003;72:710-716.
19. Oksenberg JR, Barcellos LF, Cree BCA, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004;74:160-167.
20. Xu W, Humphries S, Tomita M, et al. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease. Nitric Oxide 2000;4:379-383.
21. Morris BJ, Glenn CL, Wilcken DE, Wang XL. Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease. Clin Sci 2001;100:551-556.
22. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-266.
23. Clayton D, Jones H. Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet 1999;65:1161-1169.
24. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
25. Sobel E, Papp JC, Lange K. Detection and integration of genotyping errors in statistical genetics. Am J Hum Genet 2002;70:496-508.
26. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-927.
27. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000;67:146-154.
28. Ott J. Analysis of human genetic linkage. 3rd ed. Baltimore, MD: Johns Hopkins University Press, 1999.
29. Hauser ER, Boehnke M. Genetic linkage analysis of complex genetic traits by using affected sibling pairs. Biometrics 1998;54:1238-1246.
30. Schmidt S, Barcellos LF, DeSombre K, et al. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am J Hum Genet 2002;70:708-717.
31. The Transatlantic Multiple Sclerosis Cooperative. A meta-analysis of genomic screens in multiple sclerosis. Mult Scler 2001;7:3-11.
32. Bo L, Dawson TM, Wesselingh S, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36:778-786.
33. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997;100:2417-2423.
34. Gavrilyuk V, Horvath P, Weinberg G, Feinstein DL. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J Neurochem 2001;78:129-140.
35. Giovannoni G, Heales SJ, Land JM, Thompson EJ. The potential role of nitric oxide in multiple sclerosis. Mult Scler 1998;4:212-216.
36. Garthwaite G, Goodwin DA, Batchelor AM, et al. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 2002;109:145-155.
37. Acar G, Idiman F, Idiman E, et al. Nitric oxide as an activity marker in multiple sclerosis. J Neurol 2003;250:588-592.
38. Cross AH, Misko TP, Lin RF, et al. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994;93:2684-2690.
39. Brenner T, Brocke S, Szafer F, et al. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 1997;158:2940-2946.
40. Sahrbacher UC, Lechner F, Eugster HP, et al. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol 1998;28:1332-1338.
41. Xu C, Hillert J. Absence of linkage with the neuronal nitric oxide synthase (NOS1) gene in 41 multiplex Swedish MS families. Eur J Neurol 1998;5:393-396.
42. Blanco Y, Yague J, Graus F, Saiz A. No association of inducible nitric oxide synthase gene (NOS2A) to multiple sclerosis. J Neurol 2003;250:598-600.
43. Modin H, Dai Y, Masterman T, et al. No linkage or association of the nitric oxide synthase genes to multiple sclerosis. J Neuroimmunol 2001;119:95-100.
44. Johannesen J, Pie A, Pociot F, et al. Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes. J Clin Endocrinol Metab 2001;86:2792-2796.
45. Warpeha KM, Xu W, Liu L, et al. Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 1999;13:1825-1832.
46. Kun JF, Mordmuller B, Perkins DJ, et al. Nitric oxide synthase 2 (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 2001;184:330-336.
47. Hobbs MR, Udhayakumar V, Levesque MC, et al. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 2002;360:1468-1475.
48. Xu W, Charles IG, Liu L, et al. Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). Biochem Biophys Res Commun 1996;219:784-788.
49. Daff S, Sagami I, Shimizu T. The 42-amino acid insert in the FMN domain of neuronal nitric-oxide synthase exerts control over Ca(2+)/calmodulin-dependent electron transfer. J Biol Chem 1999;274:30589-30595.